[HB-EGF therapy for chronic heart failure].
Takashima
Seiji
S
Osaka University Health Care Center.
Hori
Masatsugu
M
D000818:Animals; D002316:Cardiotonic Agents; D002908:Chronic Disease; D004815:Epidermal Growth Factor / Q000502:physiology / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D066257:Heparin-binding EGF-like Growth Factor; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D032383:Myocytes, Cardiac / Q000502:physiology; D015398:Signal Transduction
D002316:Cardiotonic Agents; C587883:HBEGF protein, human; D066257:Heparin-binding EGF-like Growth Factor; D036341:Intercellular Signaling Peptides and Proteins; D004815:Epidermal Growth Factor